drug protocol number

4202-HEM-301

drug sponsor

Forma Therapeutics, Inc

drug study

FT-4202

drug trial site

King Khalid University Hospital (Riyadh),Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia

drug status

Ongoing

drug phase